Josep Oriola

2.3k total citations · 1 hit paper
77 papers, 1.8k citations indexed

About

Josep Oriola is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Josep Oriola has authored 77 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Endocrinology, Diabetes and Metabolism, 29 papers in Molecular Biology and 20 papers in Surgery. Recurrent topics in Josep Oriola's work include Thyroid Cancer Diagnosis and Treatment (14 papers), Pituitary Gland Disorders and Treatments (12 papers) and Growth Hormone and Insulin-like Growth Factors (11 papers). Josep Oriola is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (14 papers), Pituitary Gland Disorders and Treatments (12 papers) and Growth Hormone and Insulin-like Growth Factors (11 papers). Josep Oriola collaborates with scholars based in Spain, United States and Sweden. Josep Oriola's co-authors include Francisca Rivera, Manuel Palacı́n, António Zorzano, Marta Camps, Daniel Q. Bach, Bernhard Baumgartner, Martin D. Brand, Jorge Lloberas, Hubert Vidal and Rémi Rabasa‐Lhoret and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Gastroenterology.

In The Last Decade

Josep Oriola

74 papers receiving 1.7k citations

Hit Papers

Mitofusin-2 Determines Mitochondrial Network Architecture... 2003 2026 2010 2018 2003 200 400 600

Peers

Josep Oriola
Fangwen Rao United States
Yan Ge China
Paul Kievit United States
Kevin W. Aylor United States
Hassane Amlal United States
Fangwen Rao United States
Josep Oriola
Citations per year, relative to Josep Oriola Josep Oriola (= 1×) peers Fangwen Rao

Countries citing papers authored by Josep Oriola

Since Specialization
Citations

This map shows the geographic impact of Josep Oriola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josep Oriola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josep Oriola more than expected).

Fields of papers citing papers by Josep Oriola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josep Oriola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josep Oriola. The network helps show where Josep Oriola may publish in the future.

Co-authorship network of co-authors of Josep Oriola

This figure shows the co-authorship network connecting the top 25 collaborators of Josep Oriola. A scholar is included among the top collaborators of Josep Oriola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josep Oriola. Josep Oriola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Valdés, Nuria, María Calatayud, Cristina Lamas, et al.. (2025). Risk Factors for Pituitary Adenoma Development in Multiple Endocrine Neoplasia Type 1: A Nationwide Study of 240 Cases. The Journal of Clinical Endocrinology & Metabolism. 111(3). e811–e820. 1 indexed citations
2.
Valdés, Nuria, María Calatayud, Cristina Lamas, et al.. (2024). Long term outcomes of pituitary adenomas in Multiple Endocrine Neoplasia type 1: a nationwide study. Frontiers in Endocrinology. 15. 1427821–1427821. 3 indexed citations
3.
Álvarez‐Mora, María Isabel, Laia Rodríguez‐Revenga, Meritxell Jodar, et al.. (2023). Implementation of Exome Sequencing in Clinical Practice for Neurological Disorders. Genes. 14(4). 813–813. 4 indexed citations
4.
Ingelmo‐Torres, Mercedes, Josep Oriola, Leonardo Rodríguez‐Carunchio, et al.. (2023). Assessment of aggressive bladder cancer mutations in plasma cell-free DNA. Frontiers in Oncology. 13. 1270962–1270962. 2 indexed citations
5.
Bádenas, Célia, Jordi L. Reverter, Míriam Potrony, et al.. (2020). Lack of Mutations in POT1 Gene in Selected Families with Familial Non-Medullary Thyroid Cancer. Hormones and Cancer. 11(2). 111–116. 11 indexed citations
6.
Lamas, Cristina, Elena Navarro, Anna Casteràs, et al.. (2019). MEN1-associated primary hyperparathyroidism in the Spanish Registry: clinical characterictics and surgical outcomes. Endocrine Connections. 8(10). 1416–1424. 16 indexed citations
7.
Oriola, Josep, et al.. (2018). Functional characterization of MODY2 mutations in the nuclear export signal of glucokinase. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(7). 2385–2394. 4 indexed citations
8.
Oriola, Josep, et al.. (2014). Lack of Glibenclamide Response in a Case of Permanent Neonatal Diabetes Caused by Incomplete Inactivation of Glucokinase. JIMD Reports. 20. 21–26. 4 indexed citations
9.
Puig‐Domingo, Manel, Josep Oriola, Irene Halperín, et al.. (2011). Prevalence of germline mutations of AIP gene in sporadic aggressive somatotropinomas. 26. 1 indexed citations
10.
Oriola, Josep, et al.. (2011). Association of p.His38Leu, a Rare <i>CYP21A2</i> Mutation, with the Classical Simple Virilizing Phenotype of 21-Hydroxylase Deficiency in a 6-Year-Old Boy. Hormone Research in Paediatrics. 76(3). 214–217. 1 indexed citations
11.
Mora, Mireia, et al.. (2011). Aging phenotype and its relationship with IGF-I gene promoter polymorphisms in elderly people living in Catalonia. Growth Hormone & IGF Research. 21(3). 174–180. 13 indexed citations
12.
Oriola, Josep. (2005). Hiperplasia suprarrenal congénita por déficit de 21-hidroxilasa. ¿Cuándo es necesario conocer el genotipo?. Endocrinología y Nutrición. 52(7). 331–332. 1 indexed citations
13.
Bach, Daniel Q., Sara Pich, Francesc X. Soriano, et al.. (2003). Mitofusin-2 Determines Mitochondrial Network Architecture and Mitochondrial Metabolism. Journal of Biological Chemistry. 278(19). 17190–17197. 682 indexed citations breakdown →
14.
Aguilera, Eva, Mónica Recasens, Rosa Morı́nigo, et al.. (2003). Características clínicas, metabólicas, inmunológicas y genotípicas de un grupo de adolescentes y adultos con diabetes mellitus tipo 1A. Inicio y pronóstico a corto plazo. Medicina Clínica. 120(4). 121–124. 1 indexed citations
15.
Oriola, Josep, et al.. (2001). Screening of selected genomic areas potentially involved in thyroid neoplasms. European Journal of Cancer. 37(18). 2470–2474. 13 indexed citations
16.
Gómez-Angelats, Elisenda, Àngels Sierra, Montserrat Enjuto, et al.. (2000). Lack of association between ACE gene polymorphism and left ventricular hypertrophy in essential hypertension. Journal of Human Hypertension. 14(1). 47–49. 18 indexed citations
17.
Torregrosa, José‐Vicente, Esteban Poch, Josep Oriola, et al.. (1999). Postrenal transplant erythrocytosis and insertion/deletion polymorphism of the angiotensin converting enzyme gene. Transplantation Proceedings. 31(6). 2319–2320. 3 indexed citations
18.
Fernández‐Llama, Patricia, Esteban Poch, Josep Oriola, et al.. (1998). Angiotensin converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis. Kidney International. 53(6). 1743–1747. 68 indexed citations
19.
Jiménez, Wladimiro, Santiago Lamas, Marta Bosch‐Marcé, et al.. (1995). Endothelin 1 does not play a major role in the homeostasis of arterial pressure in cirrhotic rats with ascites. Gastroenterology. 108(6). 1842–1848. 47 indexed citations
20.
Oriola, Josep, et al.. (1991). Rsal Polymorphism of the human growth hormone gene (GH1). Nucleic Acids Research. 19(24). 6983–6983. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026